OM

Opaleye Management Portfolio holdings

AUM $758M
1-Year Est. Return 124.8%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+124.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$758M
AUM Growth
+$493K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
62
New
Increased
Reduced
Closed

Top Buys

1
+$23.3M
2
+$15.3M
3
+$14.7M
4
MGTX icon
MeiraGTx Holdings
MGTX
+$13.2M
5
QTTB icon
Q32 Bio
QTTB
+$4.95M

Top Sells

1
+$47.2M
2
+$20.1M
3
+$17.9M
4
ALKS icon
Alkermes
ALKS
+$13.7M
5
OCUL icon
Ocular Therapeutix
OCUL
+$9.48M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLMD icon
26
Relmada Therapeutics
RLMD
$756M
$6.51M 0.86%
935,000
CGON icon
27
CG Oncology
CGON
$5.49B
$6.42M 0.85%
94,800
-315,200
JBIO
28
Jade Biosciences
JBIO
$1.04B
$6.01M 0.79%
427,608
OCUL icon
29
Ocular Therapeutix
OCUL
$1.97B
$5.08M 0.67%
600,000
-995,000
ASRT icon
30
Assertio
ASRT
$151M
$5.06M 0.67%
265,707
-19,293
EDIT icon
31
Editas Medicine
EDIT
$531M
$4.76M 0.63%
+1,926,997
STRO icon
32
Sutro Biopharma
STRO
$484M
$4.75M 0.63%
190,671
DERM icon
33
Journey Medical
DERM
$174M
$4.5M 0.59%
960,000
-15,000
VYGR icon
34
Voyager Therapeutics
VYGR
$234M
$4.44M 0.59%
1,150,000
-46,904
TRVI icon
35
Trevi Therapeutics
TRVI
$2.01B
$4.12M 0.54%
345,100
TECX
36
Tectonic Therapeutic
TECX
$588M
$3.8M 0.5%
123,000
-91,747
CABA icon
37
Cabaletta Bio
CABA
$616M
$3.71M 0.49%
1,380,000
+480,000
BDSX icon
38
Biodesix
BDSX
$169M
$3.45M 0.46%
+238,047
RCKT icon
39
Rocket Pharmaceuticals
RCKT
$335M
$3.42M 0.45%
955,000
ZNTL icon
40
Zentalis Pharmaceuticals
ZNTL
$285M
$3.31M 0.44%
1,412,656
+11,750
NTLA icon
41
Intellia Therapeutics
NTLA
$1.97B
$3.14M 0.41%
+245,000
FBIO icon
42
Fortress Biotech
FBIO
$93M
$2.91M 0.38%
1,042,000
-48,000
IRD
43
Opus Genetics
IRD
$355M
$2.25M 0.3%
1,120,000
RIGL icon
44
Rigel Pharmaceuticals
RIGL
$564M
$1.89M 0.25%
70,000
AVIR icon
45
Atea Pharmaceuticals
AVIR
$374M
$1.74M 0.23%
322,600
+142,785
LYEL icon
46
Lyell Immunopharma
LYEL
$404M
$1.59M 0.21%
+79,097
ENTA icon
47
Enanta Pharmaceuticals
ENTA
$383M
$1.58M 0.21%
125,000
+50,000
NXTC icon
48
NextCure
NXTC
$22.4M
$1.51M 0.2%
+141,181
FDMT icon
49
4D Molecular Therapeutics
FDMT
$518M
$1.05M 0.14%
+112,291
PLX icon
50
Protalix BioTherapeutics
PLX
$170M
$738K 0.1%
340,000
-2,138,176
1
2
3